Datasets:

---

hfmlsoc

/

sp500_2022_2025_ai_statements_only

like 0

Follow

Hugging Face ML & Society Team 30

[{"analysis":"This statement provides specific R&D expenditure figures for three consecutive years, (...TRUNCATED)

[{"analysis":"This statement directly reports the company's R&D expenses over three years, providing(...TRUNCATED)

[{"analysis":"This statement directly describes Abbott's commitment to research and development effo(...TRUNCATED)

[{"analysis":"Directly discusses Abbott's R&D spending increase in the first quarter of 2022, includ(...TRUNCATED)

[{"analysis":"The statement directly reports an increase in the company's R&D expenses for Q2 2022, (...TRUNCATED)

[{"analysis":"The statement describes impairment charges related to in-process R&D (IPR&D) assets wi(...TRUNCATED)

[{"analysis":"The statement directly reports the company's R&D spending increase, quantifying R&D ef(...TRUNCATED)

[{"analysis":"The statement describes Abbott accounting for $15 million in in-process research and d(...TRUNCATED)

[{"analysis":"Directly refers to an in-process research and development asset, indicating ongoing R&(...TRUNCATED)

[{"analysis":"Directly states R&D expense changes compared to prior year, clearly about research and(...TRUNCATED)

[{"analysis":"This statement explicitly identifies in-process research and development (IPR&D) as a (...TRUNCATED)

[{"analysis":"This statement provides a factual update on Abbott's R&D spending, noting an increase (...TRUNCATED)

[{"analysis":"The statement directly reports the company's R&D investment as a percentage of sales, (...TRUNCATED)

[{"analysis":"This statement directly discusses Abbott's R&D efforts to advance their pipeline and s(...TRUNCATED)

[{"analysis":"Company describes internal R&D efforts for PSA technology, including conducting two de(...TRUNCATED)

[{"analysis":"CEO explicitly identifies AI as Abbott's key opportunity for personalization in the Li(...TRUNCATED)

[{"analysis":"Describes clinical trial results (TRILUMINATE study) supporting product efficacy, dire(...TRUNCATED)

[{"analysis":"This statement directly discusses Abbott's strategic investment in R&D pipeline and th(...TRUNCATED)

[{"analysis":"This describes Abbott's R&D investment in a new diagnostic system for a new market seg(...TRUNCATED)

[{"analysis":"Directly references Abbott's R&D activities and location, specifying US-based R&D as p(...TRUNCATED)

[{"analysis":"This statement explicitly describes the company's investment in R&D activities for exp(...TRUNCATED)

[{"analysis":"Direct statement about AbbVie's R&D efforts and their potential failure to produce com(...TRUNCATED)

[{"analysis":"This statement directly describes AbbVie's investment in research and development acti(...TRUNCATED)

[{"analysis":"This statement describes AbbVie's current investment in R&D and the scope of their cli(...TRUNCATED)

[{"analysis":"AbbVie reports its share of development costs related to a collaboration with Genentec(...TRUNCATED)

[{"analysis":"This statement directly describes AbbVie's reliance on ongoing research and developmen(...TRUNCATED)

[{"analysis":"This statement directly reports AbbVie's research and development spending as part of (...TRUNCATED)

[{"analysis":"Directly discusses R&D expenses related to acquired intellectual property and developm(...TRUNCATED)

[{"analysis":"Describes evaluation of a drug candidate (ABBV-552) for development, directly related (...TRUNCATED)

[{"analysis":"The statement describes AbbVie's shared research and development (R&D) activities and (...TRUNCATED)

[{"analysis":"The company explicitly states ongoing evaluation of R&D operations for optimization op(...TRUNCATED)

[{"analysis":"Directly states that research and innovation are fundamental to AbbVie's business mode(...TRUNCATED)

[{"analysis":"This statement describes AbbVie's ongoing evaluation of its R&D operations to identify(...TRUNCATED)

[{"analysis":"This statement describes a specific R&D activity (preclinical development) for a thera(...TRUNCATED)

[{"analysis":"This statement directly addresses the company's R&D pipeline progress and future plans(...TRUNCATED)

[{"analysis":"Describes AbbVie's R&D efforts in early-stage oncology programs for solid tumors.","co(...TRUNCATED)

[{"analysis":"This statement describes specific regulatory milestones achieved in the immunology R&D(...TRUNCATED)

[{"analysis":"Direct statement about AbbVie's increased R&D investment over time, showing commitment(...TRUNCATED)

[{"analysis":"This statement describes a regulatory milestone achieved through R&D efforts for a dru(...TRUNCATED)

[{"analysis":"AbbVie mentions using their proprietary 'Alle platform' to improve digital products an(...TRUNCATED)

[{"analysis":"Directly references AbbVie's research and development programs and their anticipated f(...TRUNCATED)

[{"analysis":"Directly discusses AbbVie's increased R&D investment and specific pipeline programs it(...TRUNCATED)

[{"analysis":"This statement directly describes AbbVie's R&D efforts and their commitment to maintai(...TRUNCATED)

[{"analysis":"This describes a regulatory milestone achieved through R&D efforts, expanding a drug's(...TRUNCATED)

[{"analysis":"This statement describes positive clinical trial results for a drug (tavapadon) in dev(...TRUNCATED)

[{"analysis":"This statement describes recent R&D accomplishments with specific drug approvals acros(...TRUNCATED)

[{"analysis":"This statement describes AbbVie's R&D strategy of expanding its pipeline through strat(...TRUNCATED)

[{"analysis":"Directly describes Accenture's adoption of AI (generative AI) and compute infrastructu(...TRUNCATED)

[{"analysis":"Direct prediction about generative AI's transformative impact on Accenture's business (...TRUNCATED)

[{"analysis":"Direct statement about Accenture's strategic investment in generative AI to capture ne(...TRUNCATED)

[{"analysis":"This statement describes client demand for AI solutions as part of Accenture's managed(...TRUNCATED)

[{"analysis":"This statement indicates client demand for AI as part of operations transformation, wh(...TRUNCATED)

[{"analysis":"The statement indicates client demand for AI as part of their operational transformati(...TRUNCATED)

[{"analysis":"This statement describes how Accenture's consulting revenue is directly driven by help(...TRUNCATED)

[{"analysis":"This statement directly discusses Accenture's work with clients on implementing AI sol(...TRUNCATED)

[{"analysis":"This statement describes Accenture's use of AI and predictive analytics to deliver per(...TRUNCATED)

[{"analysis":"Directly references AI and automation as key components of a banking transformation so(...TRUNCATED)

[{"analysis":"Directly identifies Cloud Data and AI as essential components for building a strong di(...TRUNCATED)

[{"analysis":"Identifies AI as a key technology area driving client strategies and fundamental to Ac(...TRUNCATED)

[{"analysis":"Accenture describes using generative AI to automate email processing for a multination(...TRUNCATED)

[{"analysis":"Directly references growing client interest in generative AI and its role in technolog(...TRUNCATED)

[{"analysis":"Direct statement about Accenture's leadership position in generative AI and its strate(...TRUNCATED)

[{"analysis":"Accenture states its leadership position in generative AI and its strategic importance(...TRUNCATED)

[{"analysis":"Describes Accenture's use of GenAI to deliver cost savings for clients, directly linki(...TRUNCATED)

[{"analysis":"Reports Accenture's GenAI bookings and revenue growth, directly showing adoption and f(...TRUNCATED)

[{"analysis":"Directly describes client adoption progression of GenAI from proof-of-concept to large(...TRUNCATED)

[{"analysis":"Direct statement about Adobe's AI technology (Adobe Sensei) being used to enhance docu(...TRUNCATED)

[{"analysis":"Adobe explains their development of proprietary AI foundation models to ensure commerc(...TRUNCATED)

[{"analysis":"Describes Adobe's strategy for developing proprietary AI foundation models while partn(...TRUNCATED)

[{"analysis":"This statement describes AI features included in Adobe's Creative Cloud product as par(...TRUNCATED)

[{"analysis":"This statement describes Adobe's integration of machine learning and artificial intell(...TRUNCATED)

[{"analysis":"Describes Figma's product as a web-based design platform, which is a type of software.(...TRUNCATED)

[{"analysis":"This statement directly discusses Adobe's investments in R&D, specifically mentioning (...TRUNCATED)

[{"analysis":"This statement describes Adobe's software delivery model, specifically mentioning SaaS(...TRUNCATED)

[{"analysis":"Adobe released Adobe Firefly, a group of creative generative AI models, after Septembe(...TRUNCATED)

[{"analysis":"This statement describes Adobe's initiative to integrate AI into their products in a r(...TRUNCATED)

[{"analysis":"Direct statement about Adobe's AI strategy to empower creators with responsible AI imp(...TRUNCATED)

[{"analysis":"Describes Adobe's generative AI models for creative content creation.","context":"Crea(...TRUNCATED)

[{"analysis":"This statement refers to Adobe's subscription revenue from its Digital Media and Digit(...TRUNCATED)

[{"analysis":"This statement directly describes Adobe's use of its AI engine (Adobe Sensei) to enhan(...TRUNCATED)

[{"analysis":"This statement describes Adobe's R&D investment in AI features for their flagship prod(...TRUNCATED)

[{"analysis":"Directly addresses how the Figma acquisition will impact Adobe's research and developm(...TRUNCATED)

[{"analysis":"This statement directly discusses Adobe's generative AI technology being integrated in(...TRUNCATED)

[{"analysis":"This statement describes Adobe's demonstration of generative AI technology at their MA(...TRUNCATED)

[{"analysis":"Describes adoption metrics for Adobe's generative AI product Firefly.","context":"Our (...TRUNCATED)

[{"analysis":"Describes the commercial availability and integration of generative AI capabilities ac(...TRUNCATED)

[{"analysis":"This statement describes Adobe's strategic approach to investing in AI across data, mo(...TRUNCATED)

[{"analysis":"Directly describes Adobe's AI feature (Firefly) adoption and usage metrics in its Phot(...TRUNCATED)

[{"analysis":"Adobe describes their investment in developing and integrating Firefly AI models into (...TRUNCATED)

[{"analysis":"This statement describes Adobe's specific AI strategy, highlighting their differentiat(...TRUNCATED)

[{"analysis":"Directly states Adobe's development and introduction of generative AI models as part o(...TRUNCATED)

[{"analysis":"Adobe views AI as a strategic opportunity to enhance their technology platforms and se(...TRUNCATED)

[{"analysis":"Directly describes AMD's strategic focus on AI development across multiple computing e(...TRUNCATED)

[{"analysis":"Directly states AMD's belief in AI's centrality to their products and their roadmap fo(...TRUNCATED)

[{"analysis":"This statement expresses AMD's strategic view on AI's role in computing and its expect(...TRUNCATED)

[{"analysis":"This statement describes AMD's announcement of AI-focused technology including the Ins(...TRUNCATED)

[{"analysis":"This statement directly describes AMD's acquisition of Pensando to enhance capabilitie(...TRUNCATED)

[{"analysis":"This statement directly describes the company's in-process research and development ac(...TRUNCATED)

[{"analysis":"This statement describes how AMD's acquisition of Pensando directly expands its comput(...TRUNCATED)

[{"analysis":"This statement directly reports AMD's R&D expense increase, showing their investment i(...TRUNCATED)

[{"analysis":"Directly states increased R&D investment in AI as a reason for decreased operating inc(...TRUNCATED)

[{"analysis":"This statement identifies AI accelerators as a specific product category within AMD's (...TRUNCATED)

[{"analysis":"Refers to the company's development and product offerings of hardware specifically des(...TRUNCATED)

[{"analysis":"This statement indicates AMD's product portfolio includes AI Accelerators, which are h(...TRUNCATED)

[{"analysis":"Refers to AMD's AI accelerator products within their Data Center segment.","context":"(...TRUNCATED)

[{"analysis":"AMD is launching a new software suite specifically designed for AI applications.","con(...TRUNCATED)

[{"analysis":"AMD is implementing AI strategy across multiple computing environments including cloud(...TRUNCATED)

[{"analysis":"This statement directly describes AMD's involvement in the PyTorch Foundation, which i(...TRUNCATED)

[{"analysis":"Describes the technical foundation of Ryzen AI, AMD's on-chip AI inference engine in p(...TRUNCATED)

[{"analysis":"Describes AMD's expansion of software ecosystem support for Instinct GPUs, specificall(...TRUNCATED)

[{"analysis":"AMD's update to ROCm software, a key AI platform, enhances hardware performance for de(...TRUNCATED)

[{"analysis":"Directly discusses AMD's progress on AI hardware and software road maps and customer m(...TRUNCATED)

[{"analysis":"Describes AMD's focus on a multi-generational AI accelerator roadmap beyond current pr(...TRUNCATED)

[{"analysis":"AMD's leadership statement on AI's transformative role in personal computing, emphasiz(...TRUNCATED)

[{"analysis":"Direct statement about AMD's AI accelerator product revenue performance, specifically (...TRUNCATED)

[{"analysis":"Directly reports growth in AI accelerator adoption across cloud, OEM, and AI customer (...TRUNCATED)

[{"analysis":"Directly describes AI hardware performance improvement for the next-generation acceler(...TRUNCATED)

[{"analysis":"This statement directly describes AMD's progress in AI infrastructure projects for sov(...TRUNCATED)

[{"analysis":"This statement directly describes Fluence, a joint venture by AES, providing AI-enable(...TRUNCATED)

[{"analysis":"This statement directly addresses the company's recognition of growing demand for data(...TRUNCATED)

[{"analysis":"","context":"","statement":"","topic":""},{"analysis":"The company explicitly states o(...TRUNCATED)

[{"analysis":"Mentions investment in new technologies but is too vague to specifically relate to sof(...TRUNCATED)

[{"analysis":"AES describes strategic investments in Uplight (energy management software) and Maximo(...TRUNCATED)

[{"analysis":"This statement describes a specific digital platform (Fluence IQ) that is part of Flue(...TRUNCATED)

[{"analysis":"This statement directly describes the company's implementation of AI and data analytic(...TRUNCATED)

[{"analysis":"AES is developing proprietary software for energy efficiency that utilizes AI for grid(...TRUNCATED)

[{"analysis":"AES states they will pursue AI as an efficiency improvement for their company, indicat(...TRUNCATED)

[{"analysis":"This statement describes how generative AI is being used internally to improve efficie(...TRUNCATED)

[{"analysis":"Directly states AES's role in providing renewable energy specifically for data center (...TRUNCATED)

[{"analysis":"This statement directly references the company's information technology systems and de(...TRUNCATED)

[{"analysis":"The statement directly mentions the company's investment in developing and using artif(...TRUNCATED)

[{"analysis":"Aflac plans to continue investing in AI as part of their digital capabilities and prod(...TRUNCATED)

[{"analysis":"The statement describes modernizing a technology platform used for actuarial work, whi(...TRUNCATED)

[{"analysis":"Describes Aflac Japan's use of a proprietary virtual sales tool for online insurance a(...TRUNCATED)

[{"analysis":"Describes Aflac's efforts to modernize its actuarial technology platform, which involv(...TRUNCATED)

[{"analysis":"This statement describes Aflac Japan's use of a proprietary virtual sales tool for onl(...TRUNCATED)

[{"analysis":"Describes Aflac Japan's use of a proprietary virtual sales tool for online consultatio(...TRUNCATED)

[{"analysis":"The statement describes Aflac Japan's use of a proprietary virtual sales tool for onli(...TRUNCATED)

[{"analysis":"This statement describes Aflac Japan's use of proprietary software systems for digital(...TRUNCATED)

[{"analysis":"This statement describes a third-party cloud hosting services agreement, directly rela(...TRUNCATED)

[{"analysis":"This describes Aflac Japan's proprietary digital platform for insurance applications, (...TRUNCATED)

[{"analysis":"Describes Aflac's proprietary system for smart device-based insurance applications, fi(...TRUNCATED)

[{"analysis":"This statement describes Aflac Japan's specific progress in digitalizing their applica(...TRUNCATED)

[{"analysis":"Describes a proprietary digital platform used to provide cancer policyholder services,(...TRUNCATED)

[{"analysis":"The company explicitly states efforts to increase digital adoption for business applic(...TRUNCATED)

[{"analysis":"This statement describes Aflac's strategic focus on digitizing their platform to repla(...TRUNCATED)

[{"analysis":"The statement refers to the dental vision platform, a proprietary software system the (...TRUNCATED)

[{"analysis":"The statement describes how Agilent's software and service solutions will enable custo(...TRUNCATED)

[{"analysis":"Direct statement about ongoing R&D investment to maintain competitive position and del(...TRUNCATED)

[{"analysis":"This statement describes Agilent's software offerings for laboratory applications, spe(...TRUNCATED)

[{"analysis":"Directly states the company's R&D expense increase and reasons for it.","context":"Res(...TRUNCATED)

[{"analysis":"This statement indicates Agilent's research and development expenses as part of their (...TRUNCATED)

[{"analysis":"The company acquired advanced artificial intelligence technology, directly indicating (...TRUNCATED)

[{"analysis":"This statement directly reports on the company's R&D expenses, showing a 5% increase c(...TRUNCATED)

[{"analysis":"This describes a specific software product offered by Agilent in their Life Sciences a(...TRUNCATED)

[{"analysis":"This describes specific software products offered by Agilent in their Life Sciences an(...TRUNCATED)

[{"analysis":"This statement directly mentions research and development as an area of investment for(...TRUNCATED)

[{"analysis":"This statement explicitly describes Agilent's specific software products for laborator(...TRUNCATED)

[{"analysis":"Mentions software as a component of cell analysis business offerings, indicating its i(...TRUNCATED)

[{"analysis":"This statement describes the company's strategic reorganization of its software and in(...TRUNCATED)

[{"analysis":"Describes the intended benefits of the acquired AI technology for automating chromatog(...TRUNCATED)

[{"analysis":"This statement directly refers to the company's investments in research and developmen(...TRUNCATED)

[{"analysis":"This statement describes the introduction of a specific software product (mass Hunter (...TRUNCATED)

[{"analysis":"The company explicitly states plans to increase investment in digital and software cap(...TRUNCATED)

[{"analysis":"The company introduced AI software for data analysis as part of new products at the AS(...TRUNCATED)

[{"analysis":"The statement explicitly describes the company's strategic reallocation of R&D funding(...TRUNCATED)

[{"analysis":"The statement directly describes an acquisition of a company using artificial intellig(...TRUNCATED)

[{"analysis":"This statement directly predicts that the new organizational structure will accelerate(...TRUNCATED)

[{"analysis":"This statement directly identifies Agilent's software products (InfinityLab Assist and(...TRUNCATED)